IE45262B1 - Disodium cromoglycate in a novel from - Google Patents

Disodium cromoglycate in a novel from

Info

Publication number
IE45262B1
IE45262B1 IE1844/80A IE184480A IE45262B1 IE 45262 B1 IE45262 B1 IE 45262B1 IE 1844/80 A IE1844/80 A IE 1844/80A IE 184480 A IE184480 A IE 184480A IE 45262 B1 IE45262 B1 IE 45262B1
Authority
IE
Ireland
Prior art keywords
disodium cromoglycate
water
granules
disodium
novel
Prior art date
Application number
IE1844/80A
Other versions
IE45262L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB260676A external-priority patent/GB1569611A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to IE1844/80A priority Critical patent/IE45262B1/en
Priority claimed from IE14/77A external-priority patent/IE45260B1/en
Publication of IE45262L publication Critical patent/IE45262L/en
Publication of IE45262B1 publication Critical patent/IE45262B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Description

The present invention relates to a new form of disodium cromoglycate.
In Patent Specification No. 31503 we have described and claimed an insufflator device for use in the administration of powdered medicaments by inhalation comprising a propeller-like device for carrying a powder capsule rotatably mounted within a tubular housing by means of a shaft loosely journalled in a tapered bearing tube, the housing having a mouth10 piece whereby a user can inhale air through the device. With that device, and other devices, e.g. that described in British Patent Specification No. 1,331,216, a user inhales air through the device which causes a powder container mounted, therein to rotate. Powder within the container is fluidised and dispensed into the air stream which is inhaled by the user. Por optimum dispensing it has been found that the powdered medicament particles should be comparatively freeflowing but fine disodium cromoglycate powders are not sufficiently free-flowing.
We have now found that this problem can be mitigated or overcome by forming powdered disodium cromoglycate into small soft granules. The formation of the disodium cromoglycate into soft granules also aids the filling of the disodium cromoglycate into capsules or other containers and can enable diluents such as 45363 coarse lactose, which have in the past been incorporated into powder inhalation compositions, to be omitted from the composition.
Accordingly the present invention provides particulate disodium cromoglycate containing from 12 to 25%, and preferably from 17 to 23%, by weight of water.
The disodium cromoglycate according to the invention may be made into soft granules described and claimed in Patent Specification No. 45260.
The disodium cromoglycate according to the invention may be made by adding water in the liquid phase to disodium cromoglycate containing insufficient water.
The disodium cromoglycate according to the invention may be converted to soft granules by subject15 ing it to controlled agglomeration. This controlled agglomeration may be carried out by, for example, extruding the particles of disodium cromoglycate through an aperture.
In this process finely divided disodium cromo20 glycate, e.g. having a mean particle size in the range 0.01 to 10 microns may be subjected to an initial treatment to cause the powder particles to be selfagglomerative. This treatment may be carried out by exposing the powder particles to water.
The powder particles may be mixed with an excess of liquid water, and the moistened material passed through an aperture, e.g. a sieve such as a vibrating sieve, of approximately equal to or larger than the mesh size required in the final granules and then drying the resulting sieved material to the desired final solvent, e.g. water content. The material may then be dry granulated to give the required product.
The amount of water used in the granulation can, under certain circumstances, be critical. Thus we have found that use of greater than about 25% by weight of - 4 water may cause the granules to be too strong and dense. a a a ο The drying of the granules is preferably effected in a preheated forced convection hot air oven. The temperature of drying is desirably from 60 to 100°C, and more expecially from 80 to 90°c.
The invention will now be illustrated by the following Example.
EXAMPLE l,000g of finely ground disodium cromoglycate Cf determined water content was placed in the bowl of a planetary mixer. The calculated amount of water to bring the moisture content of the disodium cromoglycate to within the desired range was then added gradually, the sides of the mixer bowl being scraped reqularly to ensure even moisture distribution. The damp disodium cromoglycate was then passed through a vibrating sieve having a mesh size of 1,000 microns. The product was then dried in a preheated forced convection hot air oven at 85°G for 2 hours until the moisture content of the granules was in the range 5 to 8% by weight. The granules were then sieved through a 250 micron screen. The resulting granules Were found to flow well and could be filled easily into gelatin capsules.

Claims (4)

1. Particulate disodium cromoglycate containing from 12 to 25% by weight of water.
2. Disodium cromoglycate according to Claim 1 5 and containing from 17 to 23% by weight of water.
3. Disodium cromoglycate according to Claira 1 or 2 and having a mean particle siae in the range 0.01 to 10 microns.
4. Disodium cromoglycate according to Claim 1 10 and substantially as hereinbefore described in the Example.
IE1844/80A 1976-01-23 1977-01-05 Disodium cromoglycate in a novel from IE45262B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1844/80A IE45262B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate in a novel from

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB260676A GB1569611A (en) 1976-01-23 1976-01-23 Pelletised or granular medicament formulation
GB260876 1976-01-23
IE14/77A IE45260B1 (en) 1976-01-23 1977-01-05 Pelletised or granular medicament formulation
IE1844/80A IE45262B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate in a novel from

Publications (2)

Publication Number Publication Date
IE45262L IE45262L (en) 1977-07-23
IE45262B1 true IE45262B1 (en) 1982-07-28

Family

ID=27254092

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1844/80A IE45262B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate in a novel from
IE1843/80A IE45261B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate pellets or granules

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE1843/80A IE45261B1 (en) 1976-01-23 1977-01-05 Disodium cromoglycate pellets or granules

Country Status (1)

Country Link
IE (2) IE45262B1 (en)

Also Published As

Publication number Publication date
IE45262L (en) 1977-07-23
IE45261L (en) 1977-07-23
IE45261B1 (en) 1982-07-28

Similar Documents

Publication Publication Date Title
EP0072046B1 (en) Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US5260306A (en) Inhalation pharmaceuticals
US4161516A (en) Composition for treating airway disease
ES2235311T5 (en) FORMULATION OF BUDESONIDE / FORMOTEROL FOR INHALATION THAT HAS AN APPEARING DETITY OF 0.30 TO 0.36 G / ML, A PROCESS TO PREPARE THE FORMULATION AND USE OF IT.
FI65547C (en) FOERFARANDE FOER FRAMSTAELLNING AV FOER INHALERING AVSEDDA MJUKA DINATRIUMKROMOGLYKATPELLETAR
US3634582A (en) Pharmaceutical compositions
JP2010059179A (en) New formulation for inhalation having bulk density of 0.28 to 0.38 g/ml, comprising budesonide
GB2105189A (en) Inhalation drugs
HU226493B1 (en) Process and apparatus for treatment of finely divided powdered medicaments
CA2891097A1 (en) Process for making agglomerates using acoustic mixing technology
GB1569611A (en) Pelletised or granular medicament formulation
UA57765C2 (en) Novel composition for inhalation comprising terbutaline sulphate with bulk density from 0.28 to 0.38 g/ml
IE45262B1 (en) Disodium cromoglycate in a novel from
GB1569613A (en) Disodium cromoglycate in a form
GB1569612A (en) Disodium cromoglycate pellets or granules
CA1116516A (en) Medicament composition in soft pellet or granule form
AU1760899A (en) A method for making a pharmaceutical formulation
JPH0137369B2 (en)
JP4512202B6 (en) Novel formulation for inhalation with bulk density of 0.28 to 0.38 g / ML containing budesonide
JPH0142950B2 (en)

Legal Events

Date Code Title Description
MK9A Patent expired